Prestige Biologics Co., Ltd. (KOSDAQ:334970)
South Korea · Delayed Price · Currency is KRW 1,408.00
+2.00 (0.14%)
At close: Oct 8, 2026
Prestige Biologics Market Cap
Prestige Biologics has a market cap or net worth of 109.48 billion as of October 8, 2026. It is the 26,873rd most valuable company in the world and the 1,261st biggest in South Korea. Its market cap has decreased by 55.86% in one year.
Market Cap
109.48B
Enterprise Value
203.84B
Revenue
26.67B
Global Rank
Country Rank
#1,261 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since March 11, 2021, Prestige Biologics's market cap has decreased from 613.27B to 109.48B, a decrease of -82.15%. That is a compound annual growth rate of -26.56%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 109.48B | -53.61% |
| Dec 30, 2025 | 235.98B | -40.12% |
| Dec 30, 2024 | 394.06B | 46.25% |
| Dec 28, 2023 | 269.45B | 46.01% |
| Dec 29, 2022 | 184.55B | -59.28% |
| Dec 30, 2021 | 453.18B | -26.10% |
| Mar 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TiumBio | 141.93B |
| Ensol Biosciences | 131.40B |
| Y-Biologics | 125.70B |
| ViGenCell | 120.95B |
| CORESTEMCHEMON | 104.47B |
| Cell Biotech | 104.16B |
| AriBioLab | 102.81B |
| BIO-FD&C | 86.17B |